4//SEC Filing
IMMUNOTECHNOLOGY CORP 4
Accession 0001069702-04-000003
CIK 0000789097operating
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 6:22 PM ET
Size
6.4 KB
Accession
0001069702-04-000003
Insider Transaction Report
Form 4
SCHARMANN MARK A
Director
Transactions
- Sale
Common Stock
2004-09-16$0.05/sh−500,000$24,250→ 27,973,760 total
Holdings
- 7,250(indirect: Shares held by Troika Capital, Inc., an entity controlled by the Reporting Person)
Common Stock
- 337,500(indirect: By IRA)
Common Stock
Documents
Issuer
IMMUNOTECHNOLOGY CORP
CIK 0000789097
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000789097
Filing Metadata
- Form type
- 4
- Filed
- Sep 20, 8:00 PM ET
- Accepted
- Sep 21, 6:22 PM ET
- Size
- 6.4 KB